do glp 1 drugs reduce inflammation Stories like this are why so many people are asking about GLP-1 medications. In our latest episode of the Live Yes! With Arthritis Podcast, we explore what these medications are, how they Antiinflammatory actions of glucagon-like peptide-1–based

Other ASCO-presented research found that people with stage I, II, or III lung, breast, colorectal, or liver cancer who took a GLP-1 drug were less likely to progress to stage IV disease than those who did not take one

FDA-approved weight management medications beyond GLP-1 agonists include: Phentermine-topiramate (Qsymia): Combination sympathomimetic and anticonvulsant showing 8-10% weight loss in clinical trials

However, with regard to potential limitations, we recognize that it is a retrospective study and, as such, is subject to potential missing data or data inaccuracy

This isn't Pfizer's first GLP-1 play through China either

Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes

Further solidifying 2025 as the year of updates to clinical frameworks, the European Association for the Study of Obesity released a new pharmacotherapy framework [3]